Indoco Remedies Q2 PAT grows by 40 per cent
Domestic formulation business revenues grew by 14 per cent at Rs 137.4 crores
Indoco Remedies has reported a 40 per cent growth…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
IPM clocks Rs 7738 crores in Sept 2014
The Jharkhand market grew the highest at 36.4 per cent followed by Vidarbha at 32.5 per cent
The Indian Pharma Market (IPM)…
CPhI India, P-MEC, iCSE and BioPh to be held in Mumbai
The event from December 2 to 4, 2014 will see record participation
CPhI India, P-MEC, iCSE and BioPh will be held at Bombay…
CSI with SIES Institute of Chromatography and Spectroscopy to organise symposium
Symposium to be held in Navi Mumbai on December 18 and 19, 2014
Chromatographic Society of India (CSI) has announced a two-day…
Asia Pharma Expo 2015 to be held in Bangladesh
More than 470 exhibiting companies from 28 countries will participate
Asia Pharma Expo 2015 (APE2015), the 7th international…
Social Media Week focuses on ‘Impact of Social Media in Healthcare Sector’
Patient engagement and community building are the unexplored mediums
Social Media Week (SMW), a worldwide event exploring the…
Select Biosciences India organises triconference in Mumbai
Triconference witnesses 250 attendees from India and abroad
Drug Discovery India 2014, Drug Metabolism & Discovery ADMET,…
17th Annual IDMA – APA Pharmaceutical Analysts’ Convention held
The theme for this year’s convention was, 'Challenges in Global Quality Management'The Indian Drug Manufacturers’ Association…
Glenmark enrols first patient for phase II trial of GBR 500
The company out licensed Vatelizumab (GBR 500) to Sanofi for all indications in 2011
Ranbaxy obtains US FDA approval to market fenofibrate capsules
Fenofibrate capsules are indicated for primary hypercholesterolemia and mixed dyslipidemia. In addition, it is indicated for…